Evolution of the Average Target: BlossomHill Therapeutics, Inc.

Evolution of the Average Target - BlossomHill Therapeutics, Inc.

Evolution of the Target Price: BlossomHill Therapeutics, Inc.

Evolution of the Target Price - BlossomHill Therapeutics, Inc.

Changes in Analyst Recommendations: BlossomHill Therapeutics, Inc.

10e872dd7fb84a3ada6889f9c1f5.u4rMQSwa1YOFT60W9wYksS-rGUPKXnILoUr7K8zUWnM.i8Cqc21CjPHHNthYgmd32BnBKg29ByRHywaYZZvsI0XexPUUH0rttNIk3g~efece09d4c67f416dfbcd34b520a7d48

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - +123.91%
+35.78%
+28.93%
+10.89%
+8.75%
+14.18%
+37.21%
+37.85%
+32.7%
+4.59%
Average +33.48%
Weighted average by Cap. +23.95%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
15.81USD
Average target price
35.40USD
Spread / Average Target
+123.91%
High Price Target
40.00USD
Spread / Highest target
+153.00%
Low Price Target
30.00USD
Spread / Lowest Target
+89.75%

Analyst Consensus Detail

Analyst consensus - BlossomHill Therapeutics, Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - BlossomHill Therapeutics, Inc.
  1. Stock Market
  2. Stocks
  3. BLSM Stock
  4. Consensus BlossomHill Therapeutics, Inc.